V. Grosso

发表

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

F. Pappalardo, S. Motta, P. Lollini, 2010, Cancer research.

Cancer esearch rated Systems and Technologies : Mathematical Oncology ilico Modeling and In vivo Efficacy of R cer-Preventive Vaccinations

F. Pappalardo, S. Motta, P. Lollini, 2010 .

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis

G. Benegiamo, P. Lollini, M. Iezzi, 2015, Breast Cancer Research.

Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus

P. Lollini, M. Iezzi, P. Nanni, 2013, PLoS pathogens.

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases

P. Lollini, P. Nanni, F. Alviano, 2015, Oncotarget.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

P. Lollini, M. Iezzi, P. Nanni, 2012, British Journal of Cancer.

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

P. Lollini, C. García-echeverría, K. Scotlandi, 2010, European journal of cancer.

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice

P. Lollini, P. Nanni, A. Palladini, 2013, Oncotarget.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

M. Penichet, P. Lollini, M. Iezzi, 2014, Breast Cancer Research.

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

P. Lollini, P. Picci, P. Nanni, 2014, Oncotarget.

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.

Enzo Medico, Roberto Piva, Alberto Zamò, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

P. Lollini, M. Iezzi, P. Nanni, 2012, PloS one.

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

P. Musiani, P. Lollini, M. Iezzi, 2009, Vaccine.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

P. Lollini, P. Nanni, C. De Giovanni, 2011, Vaccine.